3 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow Blepharoptosis: new trials by email Literature Review of Blepharoptosis trials Research Report on Blepharoptosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LEV102 Topical Gel in Acquired Blepharoptosis LEV102 1.0%, LEV102 2.0%, Vehicle - Acquired Blepharoptosis | Phase 1 / Phase 2 | Completed | Levation Pharma, Ltd. | 33 | 2023-02-23 | 2024-11-13 |
| Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon) XOPH5 Ointment, Placebo - Lower Eyelid Steatoblepharon (Excess Eyelid Fat) | Phase 2 | Completed | Topokine Therapeutics, Inc. | 90 | 2014-09-01 | 2016-02-08 |
| Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis RVL-1201, RVL-1201 Vehicle Placebo - Blepharoptosis | Phase 1 / Phase 2 | Completed | RVL Pharmaceuticals, Inc. | 46 | 2013-05-01 | 2021-11-26 |
Cutis Laxa (1)
Eye Diseases (3) · Eyelid Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Genetic Diseases, Inborn (1) · Skin Diseases (1) · Skin Diseases, Genetic (1) · Skin and Connective Tissue Diseases (1)
Levation Pharma, Ltd. (1) · RVL Pharmaceuticals, Inc. (1) · Topokine Therapeutics, Inc. (1)
United States (3)
Chuck Slonim, MD (1) · Houman D Hemmati, MD PhD (1) · Michael S. Singer, MD, PhD (1)